← Back to All Filings

Elanco Animal Health CFO Buys $150K in Company Stock

Low SignificanceDecember 15, 2025 at 5:05:44 PM EST

Elanco Animal Health Inc

$ELAN4CIK: 0001739104

Subscribe to track ELAN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Elanco Animal Health CFO Buys $150K in Company Stock

Company: Elanco Animal Health Inc (ELAN) Form: 4 | Filed: 2025-12-15 Significance: Low

Insider: VanHimbergen Robert M Title: EVP and CFO | Relationship: Officer

Transaction: • Type: Buy • Shares: 6,950 • Price: $21.64 • Value: $150,427 • Owned After: 124,233

Key Insight: The EVP & CFO made a small open-market purchase, a generally positive signal, though the transaction size is not material relative to the company's market capitalization.

Market Context: The purchase represents a negligible 0.0014% of Elanco's $10.48 billion market cap.

Comprehensive Analysis

SEC Filing Analysis: Elanco Animal Health Inc (ELAN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The EVP and Chief Financial Officer, Robert M. VanHimbergen, purchased 6,950 shares for approximately $150,000.
  • Market Impact: The transaction is too small to be considered material, representing just 0.0014% of the company's market capitalization.

Company Information

FieldValue
CompanyElanco Animal Health Inc
Ticker SymbolELAN
CIK0001739104
IndustryPHARMACEUTICAL PREPARATIONS [2834]

Insider Information

FieldValue
NameVanHimbergen Robert M
CIK0001724169
Title/PositionEVP and CFO
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-11
Transaction CodeP (Open market purchase)
Security TypeCommon Stock
Shares Involved6,950
Price Per Share$21.6441
Total Value$150,426.50
Shares Owned After124,233
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$150,426.50
% of Market Cap0.0014%
Shares Transacted6,950
% of Shares OutstandingNot Available
Post-Transaction Ownership124,233 shares (Ownership % Not Available)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $10.48 billion, this $150k transaction is considered routine and not financially significant.
  • Ownership Concentration: Without data on total shares outstanding, the insider's ownership concentration cannot be calculated. However, the purchase modestly increases their direct holdings.
  • Transaction Significance: The purchase by a CFO is a positive signal of confidence. However, the extremely low value relative to the company's market cap (well below the 0.1% threshold for moderate significance) categorizes this as a low-significance event.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: While a CFO purchase is a bullish signal, the transaction's value is too small to have a meaningful impact on market sentiment or stock price for a company of this size.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is unlikely to influence trading volume.
  • Sentiment Indicator: Neutral. The positive insider signal is offset by the immaterial size of the trade.

Additional Context

Transaction Notes

  • Special Circumstances: The purchase was conducted in multiple transactions with prices ranging from $21.60 to $21.70. A footnote also clarifies that 7,426 shares were inadvertently omitted from a previous Form 4 balance and are now included in the total shares owned.
Topics:#SECFiling#InsiderTrading#ELAN#Form4#InsiderBuy#CFO#StockMarket#Investing#Elanco

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.